Advantage Alpha Capital Partners’s Trueblue TBI Stock Holding History
Bought
Maintained
Sold
Other funds holding TBI
RA
ACM
Advantage Alpha Capital Partners's TBI Position: Q4 2025 in Review
Advantage Alpha Capital Partners sold out of Trueblue (TBI) in Q4 2025, closing a stake of 149,172 shares — an estimated $914K sold.
Advantage Alpha Capital Partners first reported a position in TBI in Q4 2024 and held it in 4 quarters. The position peaked at $1.98M in Q4 2024. 110 funds tracked by Wall St. Rank hold TBI as of Q4 2025.
- Advantage Alpha Capital Partners reported no remaining Trueblue position as of Q4 2025 after selling out during the quarter.
- Advantage Alpha Capital Partners sold 149,172 Trueblue shares in Q4 2025, an estimated $914K.
- Advantage Alpha Capital Partners first reported a position in Trueblue in Q4 2024 and held it in 4 quarters.
- Advantage Alpha Capital Partners's Trueblue position peaked at $1.98M in Q4 2024.
- 110 funds tracked by Wall St. Rank held Trueblue as of Q4 2025.
Based on Advantage Alpha Capital Partners's 13F filing for Q4 2025.